vs

Side-by-side financial comparison of AbbVie (ABBV) and Sysco (SYY). Click either name above to swap in a different company.

Sysco is the larger business by last-quarter revenue ($20.8B vs $15.0B, roughly 1.4× AbbVie). AbbVie runs the higher net margin — 4.6% vs 1.9%, a 2.8% gap on every dollar of revenue. On growth, AbbVie posted the faster year-over-year revenue change (9.9% vs 3.0%). Over the past eight quarters, Sysco's revenue compounded faster (3.5% CAGR vs 1.8%).

AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. They have produced drugs to treat a wide range of medical issues.

Sysco is an American multinational corporation that sells, markets, and distributes food products to restaurants, healthcare and educational facilities, sports stadiums, and other venues that serve food. It also sells foodservice supplies and equipment. The company is headquartered in the Energy Corridor district of Houston, Texas.

ABBV vs SYY — Head-to-Head

Bigger by revenue
SYY
SYY
1.4× larger
SYY
$20.8B
$15.0B
ABBV
Growing faster (revenue YoY)
ABBV
ABBV
+6.9% gap
ABBV
9.9%
3.0%
SYY
Higher net margin
ABBV
ABBV
2.8% more per $
ABBV
4.6%
1.9%
SYY
Faster 2-yr revenue CAGR
SYY
SYY
Annualised
SYY
3.5%
1.8%
ABBV

Income Statement — Q1 FY2026 vs Q2 FY2026

Metric
ABBV
ABBV
SYY
SYY
Revenue
$15.0B
$20.8B
Net Profit
$697.0M
$389.0M
Gross Margin
18.3%
Operating Margin
26.6%
3.3%
Net Margin
4.6%
1.9%
Revenue YoY
9.9%
3.0%
Net Profit YoY
-46.0%
-4.2%
EPS (diluted)
$0.39
$0.81

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ABBV
ABBV
SYY
SYY
Q1 26
$15.0B
Q4 25
$16.6B
$20.8B
Q3 25
$15.8B
$21.1B
Q2 25
$15.4B
$21.1B
Q1 25
$13.3B
$19.6B
Q4 24
$15.1B
$20.2B
Q3 24
$14.5B
$20.5B
Q2 24
$14.5B
$20.6B
Net Profit
ABBV
ABBV
SYY
SYY
Q1 26
$697.0M
Q4 25
$1.8B
$389.0M
Q3 25
$186.0M
$476.0M
Q2 25
$938.0M
$531.0M
Q1 25
$1.3B
$401.0M
Q4 24
$-22.0M
$406.0M
Q3 24
$1.6B
$490.0M
Q2 24
$1.4B
$611.7M
Gross Margin
ABBV
ABBV
SYY
SYY
Q1 26
Q4 25
72.6%
18.3%
Q3 25
66.4%
18.4%
Q2 25
71.8%
18.9%
Q1 25
70.0%
18.3%
Q4 24
70.9%
18.1%
Q3 24
70.9%
18.3%
Q2 24
70.9%
18.7%
Operating Margin
ABBV
ABBV
SYY
SYY
Q1 26
26.6%
Q4 25
27.3%
3.3%
Q3 25
12.1%
3.8%
Q2 25
31.7%
4.2%
Q1 25
28.0%
3.5%
Q4 24
-9.9%
3.5%
Q3 24
26.5%
3.9%
Q2 24
27.6%
4.7%
Net Margin
ABBV
ABBV
SYY
SYY
Q1 26
4.6%
Q4 25
10.9%
1.9%
Q3 25
1.2%
2.3%
Q2 25
6.1%
2.5%
Q1 25
9.6%
2.0%
Q4 24
-0.1%
2.0%
Q3 24
10.8%
2.4%
Q2 24
9.5%
3.0%
EPS (diluted)
ABBV
ABBV
SYY
SYY
Q1 26
$0.39
Q4 25
$1.02
$0.81
Q3 25
$0.10
$0.99
Q2 25
$0.52
$1.10
Q1 25
$0.72
$0.82
Q4 24
$-0.03
$0.82
Q3 24
$0.88
$0.99
Q2 24
$0.77
$1.23

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ABBV
ABBV
SYY
SYY
Cash + ST InvestmentsLiquidity on hand
$1.2B
Total DebtLower is stronger
$12.4B
Stockholders' EquityBook value
$2.3B
Total Assets
$27.2B
Debt / EquityLower = less leverage
5.45×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ABBV
ABBV
SYY
SYY
Q1 26
Q4 25
$5.3B
$1.2B
Q3 25
$5.7B
$844.0M
Q2 25
$6.5B
$1.1B
Q1 25
$5.2B
$1.5B
Q4 24
$5.6B
$793.0M
Q3 24
$7.3B
$733.0M
Q2 24
$13.2B
$696.0M
Total Debt
ABBV
ABBV
SYY
SYY
Q1 26
Q4 25
$58.9B
$12.4B
Q3 25
$63.0B
$11.5B
Q2 25
$63.0B
$12.4B
Q1 25
$64.5B
$12.2B
Q4 24
$60.3B
$11.4B
Q3 24
$58.5B
$11.9B
Q2 24
$58.0B
$11.5B
Stockholders' Equity
ABBV
ABBV
SYY
SYY
Q1 26
Q4 25
$-3.3B
$2.3B
Q3 25
$-2.6B
$2.1B
Q2 25
$-183.0M
$1.8B
Q1 25
$1.4B
$1.9B
Q4 24
$3.3B
$2.0B
Q3 24
$6.0B
$2.2B
Q2 24
$6.8B
$1.9B
Total Assets
ABBV
ABBV
SYY
SYY
Q1 26
Q4 25
$134.0B
$27.2B
Q3 25
$133.9B
$27.0B
Q2 25
$137.2B
$26.8B
Q1 25
$136.2B
$26.3B
Q4 24
$135.2B
$25.3B
Q3 24
$143.4B
$25.9B
Q2 24
$141.9B
$24.9B
Debt / Equity
ABBV
ABBV
SYY
SYY
Q1 26
Q4 25
5.45×
Q3 25
5.54×
Q2 25
6.75×
Q1 25
45.44×
6.37×
Q4 24
18.15×
5.66×
Q3 24
9.70×
5.38×
Q2 24
8.56×
6.19×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ABBV
ABBV
SYY
SYY
Operating Cash FlowLast quarter
$525.0M
Free Cash FlowOCF − Capex
$385.0M
FCF MarginFCF / Revenue
1.9%
Capex IntensityCapex / Revenue
0.7%
Cash ConversionOCF / Net Profit
1.35×
TTM Free Cash FlowTrailing 4 quarters
$1.8B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ABBV
ABBV
SYY
SYY
Q1 26
Q4 25
$5.2B
$525.0M
Q3 25
$7.0B
$86.0M
Q2 25
$5.2B
$1.2B
Q1 25
$1.6B
$819.0M
Q4 24
$7.0B
$445.0M
Q3 24
$5.4B
$53.0M
Q2 24
$2.3B
$1.6B
Free Cash Flow
ABBV
ABBV
SYY
SYY
Q1 26
Q4 25
$4.9B
$385.0M
Q3 25
$6.6B
$-74.0M
Q2 25
$4.9B
$819.0M
Q1 25
$1.4B
$620.0M
Q4 24
$6.8B
$234.0M
Q3 24
$5.2B
$-69.0M
Q2 24
$2.0B
$1.3B
FCF Margin
ABBV
ABBV
SYY
SYY
Q1 26
Q4 25
29.4%
1.9%
Q3 25
42.1%
-0.3%
Q2 25
31.7%
3.9%
Q1 25
10.5%
3.2%
Q4 24
44.7%
1.2%
Q3 24
35.9%
-0.3%
Q2 24
14.0%
6.4%
Capex Intensity
ABBV
ABBV
SYY
SYY
Q1 26
Q4 25
2.0%
0.7%
Q3 25
2.4%
0.8%
Q2 25
1.7%
1.8%
Q1 25
1.8%
1.0%
Q4 24
1.9%
1.0%
Q3 24
1.7%
0.6%
Q2 24
1.7%
1.5%
Cash Conversion
ABBV
ABBV
SYY
SYY
Q1 26
Q4 25
2.87×
1.35×
Q3 25
37.76×
0.18×
Q2 25
5.49×
2.25×
Q1 25
1.27×
2.04×
Q4 24
1.10×
Q3 24
3.49×
0.11×
Q2 24
1.66×
2.64×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ABBV
ABBV

Segment breakdown not available.

SYY
SYY

International Foodservice Operations$4.0B19%
Fresh And Frozen Meats1$3.0B14%
Canned And Dry Products1$2.7B13%
Sygma Segment$2.1B10%
Frozen Fruits Vegetables Bakery And Other1$2.1B10%
Dairy Products1$1.5B7%
Poultry1$1.3B6%
Fresh Produce1$1.3B6%
Paper And Disposables1$1.0B5%
Seafood1$542.0M3%
Beverage Products1$390.0M2%
Other Products$289.0M1%
Equipment And Smallwares$286.0M1%

Related Comparisons